LONDON, UK / ACCESSWIRE / January 10, 2018 / Active-Investors.com has just released a free research report on Henry Schein, Inc. (NASDAQ: HSIC). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=HSIC as the Company's latest news hit the wire. On January 08, 2017, the Company announced that it has acquired controlling stake in Brazil-based ABASE, a family-owned distributor of veterinary health care products. The acquisition allows the Company to strengthen its market share in Brazil's veterinary health sector. The Company has not disclosed the financial information and other terms of the acquisition. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Henry Schein most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=HSIC

Details of the acquisition

Henry Schein has acquired controlling stake of 60% in ABASE. Jaguariuna, Brazil-based ABASE is a seller of pharmaceuticals, pet food, diagnostic equipment, and consumables for veterinary industry. Its focus is on the animal, swine, poultry, and bovine segments. Edison Baba founded ABASE in 1990 and has a strong presence in Brazil's Campinas region in the state of Sao Paulo. ABASE's revenues for FY17 was approximately $27 million. ABASE currently has an employee strength of approximately 90 people including the sales team consisting of over 45 members. ABASE's has a centralized distribution center in Jaguariuna.

On completion of the transaction, Edison Baba will continue to hold a minority stake in ABASE and manage its business operations as the Managing Director.

Henry Schein does not expect the acquisition to have any impact on its earnings in FY18, however the Company expects the transaction to be accretive from FY19 onwards.

Management Comments

Commenting on acquiring controlling stake in ABASE, Stanley M. Bergman, Chairman of the Board and CEO of Henry Schein, said:

"This ownership investment strengthens our position in Brazil's animal health market, which we established earlier this year in the state of Rio de Janeiro with our investment in Tecnew. It also diversifies our relationship with global suppliers and approximately doubles our volume in Brazil. We look forward to leveraging the expertise between Tecnew and ABASE to further advance both businesses and to focus on new opportunities to help veterinarians in Brazil run more efficient, successful practices while providing the highest quality care."

Edison Baba, Managing Director of ABASE, added:

"In combining our resources with the deep expertise of Henry Schein, a global leader in animal health, we look forward to building upon our history of steady growth. ABASE shares with Henry Schein a commitment to customer success, and we are excited to bring existing and new customers a broader array of products, value-added services, and technology solutions."

About Henry Schein's Global Animal Health business

At present, Henry Schein's Global Animal Health business is spread across 24 countries including US, Australia, New Zealand, Brazil, Canada, China, Malaysia, and 17 European countries. The Company distributes biologics, pharmaceuticals, supplies and equipment to animal health practitioners. The Company is also engaged in the development, sale, and distribution of veterinary practice management software. The Company's Global Animal Health business recorded net sales of $3.3 billion in FY16.

Henry Schein has been bolstering its veterinary health business with an aggressive growth strategy. The Company had acquired 51% stake in Rio de Janeiro, Brazil-based Tecnew, a leading distributor of animal health products, in January 2017. In May 2017 the Company opened a new National Distribution Service Center (NDSC) in Columbus, Ohio to cater to the customers in Central Ohio and streamline its operations. In October 2017, the Company completed the acquisition of Columbia, South Carolina-based Merritt Veterinary Supplies, an independent, family-owned supplier of animal health products. In December 2017, the Company announced the acquisition of eVetPractice, a Cloud-Based Veterinary Clinic Practice Management Solutions Company, to expand its veterinary technology solutions and software portfolio.

About Henry Schein Inc.

Melville, New York-based Henry Schein is the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners. The Company also caters to the dental laboratories, government and institutional health care clinics, and other alternate care sites. The Company offers a comprehensive selection of products and services including over 120,000 branded products plus Henry Schein private-brand products in stock as well as more than 180,000 additional products available as special-order items. These products are processed via a centralized and automated distribution network. Additionally, the Company also offers innovative technology solutions, including practice management software and ecommerce solutions as well as a broad range of financial services. The Company serves more than 1 million customers.

Henry Schein and its affiliates are present in over 34 countries and is supported by a global team of 22,000 people. The Company's sales for FY16 was $11.6 billion and it has grown at a compound annual rate of approximately 15% since it was listed in 1995.

Stock Performance Snapshot

January 09, 2018 - At Tuesday's closing bell, Henry Schein's stock fell 1.20%, ending the trading session at $73.45.

Volume traded for the day: 1.41 million shares.

Stock performance in the last month ? up 8.70%; and year-to-date - up 5.11%

After yesterday's close, Henry Schein's market cap was at $11.53 billion.

Price to Earnings (P/E) ratio was at 21.15.

The stock is part of the Services sector, categorized under the Medical Equipment Wholesale industry. This sector was up 0.1% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors